Clinical Guides
Gastro-oesophageal Reflux Disease
A clinically focused adult GERD guide for India, covering alarm and cardiac mimics, empirical PPI trials, endoscopy and reflux monitoring, optimized and step-down treatment, refractory symptoms, Barrett oesophagus, pregnancy, surgery and evidence limits.
MedNext Academy | 14 min read
Gastro-oesophageal Reflux Disease
A clinically focused adult GERD guide for India, covering alarm and cardiac mimics, empirical PPI trials, endoscopy and reflux monitoring, optimized and step-down treatment, refractory symptoms, Barrett oesophagus, pregnancy, surgery and evidence limits.
Summary
Gastro-oesophageal reflux disease, abbreviated GERD internationally and GORD in some guidance, is the reflux of gastric contents that causes troublesome symptoms, mucosal injury or another complication. Typical symptoms are retrosternal burning and regurgitation. They are neither perfectly sensitive nor specific: oesophageal hypersensitivity, functional heartburn, rumination, eosinophilic oesophagitis, peptic disease and cardiac ischaemia can produce overlapping complaints. Chest pressure with exertion, breathlessness, diaphoresis or cardiovascular risk must not be labelled acid reflux before urgent cardiac assessment.
In an adult with classic symptoms, no alarm features and no important cardiac concern, an empirical proton-pump inhibitor trial is reasonable. The trial is meaningful only if the medicine is taken correctly, usually before a meal, for a defined interval. Dysphagia, bleeding, anaemia, weight loss, persistent vomiting or other alarm features prompt endoscopy rather than repeated empirical treatment. Endoscopy identifies erosive oesophagitis, stricture, Barrett oesophagus, malignancy and alternative disease, but a normal examination does not exclude GERD. Ambulatory reflux monitoring establishes or refutes abnormal reflux when diagnosis remains uncertain.
Management combines targeted lifestyle measures, acid suppression and review. Weight loss in overweight people, avoiding late meals and elevating the head during sleep for nocturnal symptoms have better rationale than universal food-ban lists. Use the lowest effective PPI strategy after healing and reconsider indication periodically, while continuing maintenance for severe erosive disease or Barrett when appropriate. Persistent symptoms require phenotype-based testing, not automatic dose escalation. Anti-reflux surgery is an option only after objective confirmation and careful selection. This educational draft is reviewed and has been reviewed by the MedNext Clinical Team.
How Common Is It?
GERD is common in clinical practice, but prevalence varies with the symptom definition, recall period, language, sampling method and whether endoscopic or physiological confirmation is required. The 2019 Indian Society of Gastroenterology consensus reviewed population studies reporting a wide range, generally below the higher estimates seen in selected cohorts. Those older heterogeneous figures should not be advertised as a precise current national rate. Urbanization, obesity, diet patterns and healthcare-seeking may change burden, while many people self-treat without entering formal datasets.
Most symptomatic patients do not have severe erosive oesophagitis. Non-erosive reflux disease, reflux hypersensitivity and functional heartburn can appear clinically similar. This distinction matters because symptom counts overestimate objectively proven pathological reflux and because persistent symptoms during PPI treatment are not automatically ongoing acid exposure. Barrett oesophagus and peptic stricture occur in a minority but carry consequences disproportionate to their frequency. Risk is influenced by duration, central obesity, male sex, smoking, age and family history, not by heartburn severity alone.
Indian burden is also shaped by access. Empirical PPIs are widely available, whereas high-quality endoscopy, histology, ambulatory pH-impedance monitoring, manometry and experienced foregut surgery are concentrated in larger centres. Repeated pharmacy purchases may suppress symptoms while delaying evaluation of dysphagia or cancer. Conversely, indiscriminate endoscopy for uncomplicated short-duration heartburn strains services. A useful local audit records alarm features, PPI indication and technique, duration, endoscopic grade when present, Barrett histology, physiological testing, step-down attempts and outcomes rather than equating prescriptions with disease prevalence.
Risk Factors
Transient lower-oesophageal-sphincter relaxations are central to reflux physiology. Hiatus hernia, impaired oesophageal clearance, reduced salivary buffering, delayed gastric emptying in selected patients and an ineffective anti-reflux barrier can increase exposure. Abdominal obesity raises the pressure gradient across the diaphragm and is a consistent modifiable risk. Pregnancy promotes symptoms through hormonal and mechanical effects. Tobacco may worsen reflux and independently increases oesophageal cancer risk. Family history and male sex are more relevant to Barrett risk than to deciding whether one episode of burning is GERD.
Foods are individual triggers rather than universal causes. Large or high-fat meals, eating close to lying down, alcohol, coffee, chocolate, mint, acidic foods and spices worsen symptoms in some people, but restrictive lists unsupported by personal response can reduce quality of life without benefit. The Indian consensus discusses dietary associations from regional studies, yet association does not prove that all spicy or non-vegetarian food must be prohibited. Ask the patient to identify reproducible triggers and prioritize weight, meal timing and sleep position when relevant.
Medicines that can worsen reflux symptoms or injure the oesophagus include nitrates, calcium-channel blockers, anticholinergic agents, theophylline, sedatives, bisphosphonates, doxycycline and non-steroidal anti-inflammatory drugs through different mechanisms. Do not stop an important cardiovascular drug reflexively; reconcile indication and alternatives with the prescriber. Scleroderma, previous foregut surgery and neurological disease change motility. Barrett oesophagus risk assessment should consider age, chronic symptoms, central obesity, smoking and family history, but population screening of every person with heartburn is not supported. Helicobacter pylori status should be managed for its own indication, not manipulated to treat GERD.
Diagnosis
History
Define burning versus pressure, regurgitation, acid taste, meal and posture relationships, nocturnal waking, frequency, duration and response to antacid or PPI. Ask explicitly about dysphagia, odynophagia, food impaction, haematemesis, melaena, anaemia, weight loss, vomiting and family history of upper gastrointestinal cancer. For chest symptoms, record exertion, radiation, breathlessness, sweating, syncope and cardiovascular risks. Review pregnancy, alcohol, tobacco, obesity, medicines, prior ulcer or endoscopy, atopy and symptoms of rumination or supragastric belching.
Examination
Vital signs and cardiopulmonary examination come first when pain could be acute coronary syndrome, pulmonary embolism or another emergency. GERD often has no specific physical sign. Record weight, body mass index and waist pattern, pallor, hydration, oral or dental erosion and abdominal tenderness or mass. Examine for chronic liver disease or systemic sclerosis when indicated. A normal examination does not make dysphagia safe for empirical treatment, and epigastric tenderness does not distinguish reflux, ulcer, biliary or functional disease.
Investigations
Classic symptoms without alarm features can justify a time-limited once-daily premeal PPI trial. Endoscopy is indicated for alarm symptoms, inadequate response after verified treatment, recurrent symptoms requiring clarification and evaluation for Barrett in selected risk profiles. Biopsy normal-appearing mucosa when eosinophilic oesophagitis is possible. If endoscopy is normal and GERD is unproven, ambulatory reflux monitoring off PPI can document acid exposure. In proven GERD with persistent symptoms despite optimized therapy, impedance-pH monitoring on PPI may examine residual reflux association. High-resolution manometry evaluates dysphagia and precedes surgery; it does not diagnose GERD alone. Barium swallow is selected for structural questions, not used as a reflux screening test.
Differential Diagnosis
Acute coronary syndrome is the most dangerous mimic. Retrosternal pressure, exertional symptoms, radiation, autonomic features, haemodynamic change or significant cardiovascular risk warrants an emergency pathway even if antacid previously helped. Aortic disease, pulmonary embolism, pericarditis, pneumothorax and pneumonia are other urgent chest-pain alternatives. Relief with PPI has limited diagnostic specificity because symptoms fluctuate and placebo response is common. Musculoskeletal pain is reproducible in some cases but coexistence does not exclude cardiac disease.
Oesophageal alternatives include eosinophilic oesophagitis, achalasia, spasm, pill injury, infectious oesophagitis, stricture and cancer. Progressive solid-food dysphagia suggests obstruction; difficulty with liquids and solids from onset suggests motility disease. Rumination is effortless postprandial return of recently eaten food, while supragastric belching follows a behavioural air-flow pattern. Reflux hypersensitivity has normal acid exposure with positive symptom association; functional heartburn has normal exposure and negative association after appropriate evaluation. These phenotypes respond differently from acid-mediated GERD.
Peptic ulcer, functional dyspepsia, gastroparesis, biliary colic, pancreatitis and gastric cancer can cause epigastric or postprandial symptoms. Pregnancy-related nausea should not be reduced to reflux when dehydration is present. Chronic cough, hoarseness, asthma and globus have many causes; GERD attribution based on symptoms alone is unreliable, particularly without typical heartburn or regurgitation. Dental erosion is not specific. A persistent complaint despite PPI should trigger technique review and renewed diagnostic reasoning rather than a sequence of stronger acid suppressants without objective evidence.
Management
Explain the chronic-relapsing nature of GERD and agree on a measurable goal such as control of troublesome heartburn, healing of oesophagitis or prevention of stricture. In an overweight person, weight reduction can reduce symptoms and benefits wider health. Avoid meals within roughly three hours of lying down when nocturnal reflux occurs, elevate the head of the bed rather than adding pillows, and consider left-side sleeping. Stop smoking and moderate alcohol for general health and when personally linked to symptoms. Avoid only reproducible food triggers; a universal restrictive diet is not required.
For classic uncomplicated symptoms, use a defined once-daily PPI trial taken before a meal. If response is incomplete, verify adherence, timing and diagnosis before increasing to twice daily or changing agent. Healing severe erosive oesophagitis usually requires maintenance acid suppression. If symptoms resolve and there is no continuing indication, attempt discontinuation, on-demand use or the lowest effective dose, warning about transient rebound symptoms. H2-receptor antagonists or alginate-antacid preparations can help selected intermittent symptoms, but tolerance can limit continuous nocturnal H2 therapy. Prokinetics have little routine role without another indication such as documented gastroparesis.
Persistent symptoms after optimized therapy require objective phenotyping. Treat reflux hypersensitivity or functional heartburn with explanation and selected neuromodulatory or behavioural approaches rather than endless acid suppression. Barrett management follows a separate histology-based surveillance pathway. Anti-reflux surgery is considered for objectively proven reflux, especially with severe regurgitation, large hiatus hernia or a preference to avoid long-term medication after informed comparison. Endoscopic interventions have narrower evidence and eligibility. Neither surgery nor a device guarantees freedom from dysphagia, gas-bloat, recurrence or future medication.
Prescribing Information
PPIs work best when prescribed with precise technique: most standard formulations are taken before food so the active pumps are available for inhibition. The exact molecule, dose, frequency and timing follow the Indian product label and indication. Common adverse effects include headache, abdominal symptoms and diarrhoea. Long-term observational associations with fractures, kidney disease, dementia, cardiovascular events and other outcomes are vulnerable to confounding; patients should not be frightened into stopping a necessary PPI. Enteric infection risk is a plausible concern, and magnesium, vitamin B12, iron, renal or bone assessment should be targeted to clinical risk rather than ordered as an automatic panel for everyone.
Review interactions and duplication. Omeprazole and esomeprazole can inhibit CYP2C19 and may be undesirable with clopidogrel depending on current regulatory advice and alternatives. Acid suppression affects absorption of some medicines. H2-receptor antagonists require renal adjustment and can cause central adverse effects in frail older adults. Antacids and alginates can interfere with absorption of other drugs and should be spaced according to product information; magnesium or aluminium load matters in renal impairment.
In pregnancy, begin with meal timing, head elevation and individually tolerated dietary measures. Alginate or antacid options are selected with obstetric and pharmacy advice; avoid sodium bicarbonate and unsuitable magnesium-containing products. H2 blockers or PPIs may be used when benefit justifies treatment, guided by current pregnancy information and local practice. Severe vomiting, weight loss, bleeding or dehydration needs obstetric or medical assessment rather than escalating self-treatment. Deprescribing is a supervised indication review, not abrupt withdrawal from severe oesophagitis, Barrett oesophagus or bleeding-risk gastroprotection. Record why the PPI continues and when it will be reconsidered.
When to Refer
Arrange prompt endoscopic or specialist assessment for progressive dysphagia, odynophagia, food impaction, gastrointestinal bleeding, iron-deficiency anaemia, persistent vomiting, unexplained weight loss, an epigastric mass, or a concerning family history. Significant acute bleeding requires same-day emergency care. New chest pain with possible cardiac features belongs to an emergency cardiac pathway, not a gastroenterology waiting list. Suspected eosinophilic oesophagitis, achalasia, cancer or complicated ulcer disease also warrants directed referral.
Refer routinely when a correctly taken empirical trial fails, symptoms recur whenever therapy is stopped and the diagnosis is uncertain, or long-term high-dose treatment is being considered without objective evidence. Gastroenterology can perform endoscopy and, where available, ambulatory reflux monitoring and manometry. Referral is also appropriate for peptic stricture, severe erosive oesophagitis, biopsy-proven Barrett oesophagus, persistent regurgitation, aspiration concern or troublesome extra-oesophageal symptoms after other causes have been assessed. Include PPI molecule, dose, timing, adherence and response rather than writing only refractory GERD.
A surgical opinion requires objective GERD, review of anatomy, endoscopy, physiological testing and manometry. Large hiatus hernia, severe regurgitation or proven ongoing reflux may strengthen the case, but obesity, motility disorder, functional symptoms and unrealistic expectations change selection. In India, confirm that the receiving centre can provide reliable physiology and experienced follow-up; a procedure should not be selected solely because repeated tablets are inconvenient or testing is unavailable. Pregnancy-related severe symptoms, inability to eat or drink, bleeding or chest pain should be triaged jointly with obstetric services.
Red Flags
Treat possible acute coronary syndrome as an emergency: pressure or heaviness, exertional pain, radiation to arm, jaw or back, dyspnoea, diaphoresis, nausea, syncope or haemodynamic instability requires immediate ECG-based assessment and appropriate cardiac biomarkers. Age, diabetes and sex do not reliably create a benign presentation; ischaemia can feel like indigestion. Sudden tearing pain, hypoxia, unilateral breath sounds or pleuritic pain with thromboembolic risk indicates other cardiopulmonary emergencies. Do not delay these pathways for a trial of antacid.
Gastrointestinal emergency features include haematemesis, melaena, shock, severe anaemia, food bolus obstruction, inability to swallow saliva, perforation signs or persistent vomiting with dehydration. Progressive dysphagia, odynophagia, weight loss, unexplained iron deficiency, recurrent aspiration or an abdominal mass requires expedited investigation for malignancy or structural disease. A long history of heartburn does not protect against a new cancer, and a normal endoscopy years earlier does not negate new alarm symptoms.
Treatment-related concern includes severe or persistent diarrhoea, allergic reaction, acute kidney injury symptoms, marked electrolyte disturbance or a clinically important drug interaction. After fundoplication or another anti-reflux procedure, severe chest or abdominal pain, fever, persistent retching, inability to swallow fluids or respiratory compromise needs urgent surgical review. During pregnancy, dehydration, haematemesis, weight loss or severe upper abdominal pain merits obstetric assessment. Refractory symptoms without alarm features are not an emergency, but repeated self-escalation can obscure eosinophilic, motility or functional disease and should prompt structured reassessment.
Indian Clinical Context
The Indian Society of Gastroenterology position statement remains the most directly relevant national consensus, incorporating Indian epidemiology, symptom profiles, investigations, medical therapy, procedures and complications. It reports important regional heterogeneity and limited erosive disease in many cohorts. Because it was published in 2019, its statements should be reconciled with later ACG recommendations and current Indian product information. It is evidence-informed professional consensus, not a substitute for patient-specific assessment or a guarantee that every facility has physiology testing.
In primary care and pharmacies, PPIs are often started without a documented indication and continued without review. The practical quality intervention is to record alarm screening, cardiac assessment when relevant, dose timing, planned trial length and review date. Conversely, cost or travel should not lead to indefinite empirical treatment of dysphagia, bleeding or weight loss. District and medical-college endoscopy access is variable; pH-impedance monitoring, high-resolution manometry and experienced anti-reflux surgery are concentrated in tertiary centres. Referral should name the required test and the clinical decision it will inform.
Advice should fit Indian meals, work schedules and sleeping arrangements. Rather than banning chilli, tea, coffee or non-vegetarian food for everyone, identify reproducible triggers, reduce very large late meals and address central obesity. Pregnancy treatment should coordinate with obstetric care. Barrett surveillance requires endoscopy quality and histopathology, so intervals must not be invented when records are incomplete. International guidance can inform PPI optimization and physiological testing, but drug availability, prices and procedures differ. Where testing is inaccessible, state uncertainty, safety-net clearly and avoid irreversible intervention based on symptoms alone.
NMC Competency Mapping
GERD is integrated across NMC undergraduate medicine, surgery, pharmacology and physiology rather than represented by one stand-alone procedural license. Gastrointestinal physiology provides oesophageal motility, sphincter and gastric-secretion foundations. General medicine competencies on dyspepsia, chest pain and gastrointestinal bleeding support symptom evaluation and emergency discrimination. Surgery competencies concerning oesophagus, stomach and abdominal examination support recognition of hiatus hernia, stricture and operative principles. Pharmacology contributes rational use and adverse-effect assessment of acid-suppressing drugs.
A graduating learner should define GERD as troublesome symptoms or complications from reflux, take a precise symptom and alarm history, and treat possible cardiac pain first. They should explain when an empirical PPI trial is acceptable, how timing affects response, why endoscopy may be normal and when ambulatory reflux monitoring is used off or on therapy. They should distinguish erosive disease, non-erosive reflux, reflux hypersensitivity and functional heartburn conceptually without claiming competence to interpret specialist studies independently.
Management competence includes targeted lifestyle counselling, a time-limited treatment plan, lowest-effective-dose review and appropriate referral. Learners should recognise dysphagia, bleeding, anaemia, weight loss, vomiting and food impaction, and understand Barrett oesophagus as intestinal metaplasia with a separate biopsy and surveillance pathway. They should describe fundoplication principles and complications while recognizing that surgery requires objective evidence and manometry. Assessment should reward diagnostic restraint, cardiac safety and deprescribing review rather than indiscriminate endoscopy, permanent PPI therapy or memorized food prohibitions.
Key Exam Pearls for NEET PG
GERD results when reflux causes troublesome symptoms or complications. Heartburn and regurgitation are typical, but chest pain may be cardiac and must be risk assessed first. Alarm symptoms include progressive dysphagia, odynophagia, bleeding, iron-deficiency anaemia, weight loss, persistent vomiting and food impaction. An uncomplicated classic presentation can receive an empirical PPI trial; endoscopy is preferred with alarm features or inadequate response. A normal endoscopy does not exclude GERD.
Los Angeles grades describe erosive oesophagitis. Barrett oesophagus is replacement of distal squamous mucosa by columnar epithelium with intestinal metaplasia under commonly used definitions and carries adenocarcinoma risk. Peptic stricture causes progressive solid-food dysphagia. Ambulatory pH monitoring off PPI tests unproven GERD; impedance-pH on PPI can evaluate persistent symptoms in proven disease. Manometry diagnoses motility disorders and is required before anti-reflux surgery, but does not establish reflux alone. Barium study is not a primary GERD diagnostic test.
Take most PPIs before a meal and verify adherence before escalation. Weight loss, avoiding late meals and head-of-bed elevation for nocturnal symptoms are useful targeted measures. Step down or discontinue after symptom control when no maintenance indication exists; severe erosive oesophagitis and Barrett often justify ongoing therapy. Functional heartburn has normal reflux exposure and negative symptom association, so more acid suppression is unhelpful. Fundoplication reinforces the anti-reflux barrier but can cause dysphagia and gas-bloat and should follow objective confirmation. Prokinetics are not routine GERD treatment without another indication.
Frequently Asked Questions
When can heartburn be treated with an empirical proton-pump inhibitor trial?
A defined trial is reasonable for classic heartburn or regurgitation when cardiac disease is not suspected and there is no dysphagia, bleeding, anaemia, weight loss, persistent vomiting or other alarm feature. The PPI must be taken with correct premeal timing, and the response and continuing indication should be reviewed rather than allowing automatic indefinite renewal.
Does a normal upper gastrointestinal endoscopy rule out gastro-oesophageal reflux disease?
No. Many patients with GERD have no visible erosions. If the diagnosis remains uncertain, ambulatory reflux monitoring off acid suppression can document or refute abnormal exposure. In a person with previously proven GERD and persistent symptoms on optimized treatment, impedance-pH monitoring on therapy may assess residual reflux and symptom association.
Should every person taking a PPI long term stop because of reported adverse effects?
No. Many reported long-term harms come from observational associations and do not prove causation. Continue a PPI when benefit is established, such as severe erosive oesophagitis or an appropriate Barrett pathway, while using the lowest effective strategy and reviewing indication. Deprescribe unnecessary treatment with counselling about transient rebound symptoms, not through alarm-driven abrupt withdrawal.
When is anti-reflux surgery a reasonable option rather than continuing medicines?
Surgery may suit selected patients with objectively proven reflux, troublesome regurgitation, severe disease or a large hiatus hernia after informed comparison with medical therapy. Endoscopy, reflux testing and manometry usually form part of selection. Functional heartburn, unconfirmed symptoms or unrealistic expectations predict poor value; dysphagia, gas-bloat, recurrence and future medicine use remain possible.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic